Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
抗体-药物偶联物 Sacituzumab Govitecan 为乳腺癌患者提供 TOP1/PARP 抑制剂序贯治疗策略
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-24-0428
Aditya Bardia #, Sheng Sun #, Nayana Thimmiah #, James T Coates, Bogang Wu, Rachel O Abelman, Laura Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann Partridge, Dejan Juric, Jeffrey Peppercorn, Heather Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerl